Conclusion:
Tracheostomy in the SARS-CoV-2 infected patient represents a unique
situation, with a unique set of risks and implications. When compared to
traditional tracheostomy procedures in the setting of prolonged
ventilation, SARS-CoV-2 represents a unique entity in terms of timing,
indications, and infection control considerations which must be kept in
mind when performing these procedures and managing patient’s
post-tracheostomy. Additional resources are listed below.